Prosiectau (339)
Cardiff University Schools involved in this Project
T1D-Plus: a clinical trial platform for combined beta cell preservation therapy (01.09.2022 - 31.08.2026)
- Dayan, Colin
T1D-Plus: An adaptive trial platform for the study of combination therapies in new-onset T1D (01.12.2023 - 30.11.2026)
- Dayan, Colin
T1D UK Clinical Trials consortium - mechanistic core (01.01.2015 - 05.12.2021)
- Wong, Susan
T1D UK Immunotherapy Consortium: Clinical Engagement and Training (CET) Core (01.05.2015 - 30.03.2020)
- Dayan, Colin
TACTICC study (01.06.2015 - 31.12.2016)
- Godkin, Andrew
Take home naloxone Intervention Multi centre Emergency setting feasibility trial (TIME) (01.03.2018 - 31.08.2020)
- Edwards, Adrian
- Taking imaging into the therapeutic domain: self-regulation of brain systems for mental disorders
(01.11.2013 - 31.10.2018)- Linden, David
Talking about HPV related cancer: Development and testing of scripted consultations (01.07.2014 - 30.06.2016)
- Adams, Richard
Talking Trials: Exploration of clinical trial perceptions amongst BAME communities (01.04.2020 - 31.03.2022)
- Svobodova, Martina
Talking Trials: Participatory approaches to creating community dialogue (01.10.2022 - 31.01.2024)
- Svobodova, Martina
TAP Centre (01.01.2020 - 31.12.2022)
- Knapper, Steven
TAPERS study Excess Treatment Costs (01.10.2018 - 31.01.2022)
- Hall, Jeremy
Targeted stabilisation of human cardiac ryanodine receptors as a therapeutic strategy for cardiac disease (01.10.2009 - 30.09.2014)
- George, Christopher
Targeted vaccines for infectious disease and cancer (01.04.2010 - 30.09.2010)
- Sewell, Andrew
Targeted vaccines for infectious disease and cancer (31.03.2010 - 30.09.2012)
- Sewell, Andrew
Targeting alpha-beta - crystalline (CRYAB): A novel strategy to impede triple-negative breast cancer development (01.07.2014 - 31.01.2016)
- Cai, Jun
Targeting CD8 using “blocking anti CD8 antibodies” as a strategy to disable autoreactive CD8+ T-cells in Type 1 diabetes (01.01.2023 - 29.02.2024)
- Pearson, James
Targeting CLL cell survival and proliferation with bioactive cell penetrating peptides (01.10.2010 - 30.04.2014)
- Brennan, Paul
Targeting complement to treat fatty liver disease (01.10.2022 - 30.09.2025)
- Zhou, You
Targeting ERK signalling to emeliorate intellectual disability and autism spectrum disorder associated with chromosomal rearrangements at 16p11.2 (01.11.2019 - 31.10.2025)
- Hall, Jeremy
Targeting glucose metabolism for the treatment of Birt Hogg Dube Syndrome (01.10.2009 - 30.09.2010)
- Tee, Andrew
Targeting islet-specific CD8 Tcells in Type 1 diabetes (01.06.2015 - 31.01.2019)
- Wong, Susan
Targeting neuroinflammation in mTORC1 driven brain tumours (01.10.2019 - 31.05.2023)
- Tee, Andrew
Targeting NF-xB activation and proliferation signals in CLL (01.11.2013 - 31.07.2018)
- Pepper, Christopher
- Targeting novel anti-complement drugs to the brain for therapy of
dementia. (01.10.2021 - 31.12.2026)- Zelek, Wioleta
Targeting Ref1/STAT3 to treat Tuberous Sclerosis (01.04.2018 - 09.02.2023)
- Tee, Andrew
Targeting the CD8 coreceptor as a novel strategy for the treatment of type 1 diabetes (01.01.2013 - 31.12.2013)
Targeting the early endosome as a therapeutic strategy in neurodegenerative diseases (01.01.2024 - 14.04.2027)
- Connor-Robson, Natalie
Targeting the pathological pathways to Parkinson's (02.05.2018 - 01.08.2021)
- Webber, Caleb
Targeting the terminal pathway in complement - driven disease (30.06.2018 - 30.09.2018)
- Morgan, Paul
Targeting the terminal pathway in complement-driven disease (01.10.2016 - 30.09.2018)
- Morgan, Paul
Targeting tissue macrophage generation during inflammation as a mechanism to modulate the resolution of inflammation (31.07.2012 - 30.07.2015)
- Taylor, Philip
Targets for treatment in AML: discovery and translation (20.09.2015 - 23.08.2019)
- Darley, Richard
Targets for treatment in AML: Discovery and translation (01.04.2010 - 19.09.2013)
- Darley, Richard
Targets for treatment in AML: Discovery and translation (20.09.2013 - 01.12.2015)
- Darley, Richard
Target temperature management after cardiac arrest (01.04.2011 - 31.12.2013)
- Hood, Kerenza
Target validation, indication selection/prioritisation, review of pre-clinical validation efforts and overall strategy (08.08.2016 - 18.09.2019)
- Morgan, Paul
Taster for clinicians (10.08.2015 - 04.10.2015)
- Robertson, Neil
T cell correlates of successful immunotherapy (01.10.2015 - 30.09.2018)
- Sewell, Andrew
T-cell correlates of successful immunotherapy (01.10.2016 - 30.09.2020)
- Sewell, Andrew
T cell cross-reactivity (09.05.2018 - 18.02.2019)
- Price, David
T-cell cross-reactivity causes Type 1 diabetes (01.07.2015 - 31.10.2016)
- Bulek, Anna
T cell receptor repertoire of insulin reactive CD8 T cells (01.10.2011 - 30.09.2014)
- Wong, Susan
T-cell receptors for cancer immunotherapy (01.10.2012 - 30.09.2015)
- Sewell, Andrew
T cells, monocytes and neutrophils: Detrimental crosstalk in peritoneal dialysis-related infection. (01.04.2009 - 31.03.2013)
- Eberl, Matthias
Teaching early reading skills to adults with intellectual disabilities (READ-IT) using a support worker/family carer mediated on-line reading programme – a feasibility study (01.09.2019 - 31.03.2022)
- Gillespie, David
TED (01.12.2019 - 31.12.2021)
- Townson, Julia
Telomere based prognostication in breast cancer (01.03.2017 - 28.02.2018)
- Baird, Duncan
Telomere dynamics and dysfunction in CLL (01.09.2011 - 12.11.2014)
- Baird, Duncan
Telomere dynamics during replicative senescence and early-stage neoplasia (01.05.2005 - 30.04.2011)
- Baird, Duncan
Telomere dynamics during replicative senescence and early-stage neoplasia 2 (01.10.2006 - 30.09.2010)
- Baird, Duncan
Telomere dynamics, instability and fusion in CLL - Can telomere erosion and fusion drive progression in CLL? (01.09.2006 - 31.08.2011)
- Baird, Duncan
Telomere dynamics, instability and fusion in colorectal and prostate cancer (01.04.2010 - 31.03.2013)
- Baird, Duncan
Telomere independent senescence in an in vitro model of oncogene induced thyroid cancer (01.04.2006 - 01.04.2010)
- Poghosyan, Zaruhi
Telomere length as a biomarker of genomic instability and predictor of response to treatment (01.10.2011 - 30.09.2013)
- Pepper, Christopher
Telomere length cancer prognosis (01.02.2012 - 29.02.2012)
- Pepper, Christopher
Telomeric prognostics (01.03.2016 - 28.02.2019)
- Baird, Duncan
TENTS-TP - The European Network for Traumatic Stress - Teaching and Practice (15.05.2009 - 14.05.2011)
- Bisson, Jonathan
Test a novel approach to cleaning ambulances (01.07.2020 - 18.09.2020)
- Stanton, Richard
Testing activity of mAb CP010 (26.10.2018 - 25.10.2019)
- Morgan, Paul
Testing novel agents in myasthenia gravis models (01.06.2019 - 31.12.2020)
- Morgan, Paul
Testing novel agents in myasthenia gravis models (25.05.2015 - 31.03.2017)
- Morgan, Paul
Testing of novel LddBCNA based antivirals versus HIV hepatitis c virus (HVC) and dengueviruses and MoA (01.06.2012 - 31.01.2015)
- Bugert, Joachim
Testing of prototype diagnostic kit (15.07.2018 - 14.01.2019)
- Spiller, Brad
Testing of SARS-CoV2 (01.11.2020 - 30.11.2020)
- Stanton, Richard
Testing of the inspired oxygen levels measured in a patient model when an Atos HME is connected (01.11.2014 - 30.11.2014)
- Hall, Judith
Testing the improvement in brain penetrance therapeutic antibodies through coupling to a transporter peptide (01.05.2019 - 31.10.2019)
- Hughes, Timothy
Test of anti inflammatory properties of the pro-biotic "plantarum" in high fat fed wt black (11.01.2016 - 29.04.2016)
- Hughes, Timothy
Test on the accuracy of a new method for imaging turbulent blood flow and vortices using ultrasound data (01.05.2010 - 30.04.2012)
- Fraser, Alan
Testosterone effects and safety in men with low testosterone levels (TESTES) (01.09.2018 - 01.05.2019)
- Azzopardi, Duncan
T-FRAG: Collection and storage of tumour and blood samples from patients with lung cancer in the FRAGMATIC clinical trial for future translational research (01.05.2007 - 30.04.2013)
TG1101-RMS302 Phase III: UbLiTuximab in Multiple Sclerosis treatment effects (ULTIMATE II STUDY) (11.01.2019 - 31.01.2021)
- Robertson, Neil
TGF-B1 promoter defects and complement deficiency are integral to onset and severity of human papillomavirus-mediated juvenile-onset recurrent respiratory papillomatosis (JORRP) (01.07.2006 - 31.08.2009)
- Spiller, Brad
The A/B/C of GO: Novel assays for the diagnosis and management of Graves' orbitopathy (01.08.2014 - 31.12.2015)
The adoption of early-emerging technologies: Evaluation, innovation, gatekepping (01.05.2009 - 31.03.2012)
The aetiology of psychosis high-risk mental states during adolescence in the ALSPAC cohort (01.10.2008 - 31.03.2013)
- Zammit, Stanley
The beta-2 score and beyond: new composite outcomes measures of islet cell function for use in clinical trials (01.10.2019 - 30.06.2025)
- Dayan, Colin
The beta-2 score and beyond: new composite outcomes measures of islet cell function for use in clinical trials (01.10.2019 - 31.03.2023)
- Dayan, Colin
The body's battle against cancer (01.06.2015 - 29.02.2016)
- Gallimore, Awen
The Centre for Neuropsychiatric Genetics and Genomics (03.08.2009 - 02.08.2014)
- Owen, Michael
The Changing Minds Programme (01.05.2014 - 31.01.2021)
- Hall, Jeremy
The clinical development and service implementation of molecular monitoring to direct treatment of acute myeloid leukaemia (AML17) (01.04.2014 - 31.03.2021)
- Adams, Richard
The complotype and risk for meningitis (01.02.2013 - 01.06.2014)
- Harris, Claire
The complotype as a predictor of disease and response to therapy in AMD (01.10.2012 - 31.05.2016)
- Harris, Claire
The CONSCOP right side study (01.10.2013 - 30.09.2017)
- Hurt, Christopher
The contribution of maternally expressed imprinted genes to parental behaviour (01.12.2022 - 28.04.2026)
- Isles, Anthony
The control of multi-drug resistant bacteria using bacteriophages (01.06.2015 - 27.07.2015)
- Toleman, Mark
The detection of brain tumours by laser Raman spectroscopy (01.10.2012 - 31.03.2013)
- Gray, William
The developmental origins of health: Biology, shocks, investments, and policies (01.04.2019 - 31.03.2025)
- Robling, Michael
The development and evaluation of an interactive leaflet for children with acute respiratory tract infections (01.09.2005 - 31.08.2009)
The development and implementation of polygenic risk algorithms for stratifying individuals for future cognitive decline due to Alzheimer's disease in non-symptomatic and early cognitive impaired subjects (01.03.2018 - 29.02.2020)
- Escott-Price, Valentina
The development of a cheap and simple to use self-administratable micro-needle patch device for population-wide of sampling of small volumes of blood (01.05.2012 - 30.04.2014)
The development of an e learning programme to support retention and return to work for individuals with a diagnosis of bipolar disorder (01.01.2012 - 31.05.2013)
- Cohen, Deborah
The development of an integrated intervention for traumatic stress within prisons (01.12.2021 - 31.08.2023)
- Forrester, Andrew
The development of a novel cardiomyocyte-based high throughput screening (HTS) bioassay for identifying new anti arrhythmics (01.07.2008 - 30.06.2012)
- George, Christopher
The development of a primary immunodeficiency oligonucleotide microarray (01.07.2006 - 30.06.2010)
- Morgan, Paul
The development of a scalable sustainable researcher training programme to enhance compliant use of routine data in research (01.04.2019 - 31.10.2020)
- Robling, Michael
The development of a technology to sensitivity measure genome-wide ultraviolet light induced DNA damage for photgenotoxicity testing of human cells (01.12.2011 - 30.11.2013)
- Reed, Simon
The development of contents of an IBD training programme (01.07.2014 - 30.04.2019)
- Cohen, Deborah
The development of iBAC vectors for the functional characterisation of Alzheimer's disease susceptibility variants (01.02.2013 - 31.07.2013)